BTAIVSSTRO• 12 Months (Normalized)
BTAI vs STRO (BioXcel Therapeutics Inc. vs Sutro Biopharma Inc.)
Showing Closing Date Range from Sep, 11, 2025 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.05
-98.5%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
STRO Performance $16.86
+73.81%
Sutro Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin STRO LEADS
-172.31%
STRO outperforming by 172.31%
BTAISTRO
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI STRO
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | BTAI Price | BTAI Gain (%) | STRO Price | STRO Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $0.05 | -98.50% | $16.86 | +73.81% | -172.31% |
| Sep 10, 2026 | $0.05 | -98.53% | $17.83 | +83.81% | -182.34% |
| Sep 09, 2026 | $0.05 | -98.61% | $18.36 | +89.28% | -187.89% |
| Sep 08, 2026 | $0.04 | -98.73% | $19.10 | +96.91% | -195.64% |
| Sep 04, 2026 | $0.07 | -97.82% | $20.07 | +106.91% | -204.73% |
| Sep 03, 2026 | $0.12 | -96.52% | $20.54 | +111.75% | -208.27% |
| Sep 02, 2026 | $0.11 | -96.84% | $20.47 | +111.03% | -207.87% |
| Sep 01, 2026 | $0.14 | -95.96% | $20.82 | +114.64% | -210.60% |
| Aug 31, 2026 | $0.16 | -95.19% | $20.24 | +108.66% | -203.85% |
| Aug 28, 2026 | $0.18 | -94.66% | $20.45 | +110.82% | -205.48% |
| Aug 27, 2026 | $0.72 | -78.79% | $21.31 | +119.69% | -198.48% |
| Aug 26, 2026 | $0.78 | -76.99% | $21.43 | +120.93% | -197.92% |
| Aug 25, 2026 | $0.74 | -78.11% | $21.44 | +121.03% | -199.14% |
| Aug 24, 2026 | $0.76 | -77.55% | $20.49 | +111.24% | -188.79% |
| Aug 21, 2026 | $0.80 | -76.28% | $21.04 | +116.91% | -193.19% |
Page 1 of 17